Mga Batayang Estadistika
| LEI | 549300F3JF8NCDJJZW04 |
| CIK | 1494891 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Sensus Healthcare, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 15, 2025 |
United states SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 As filed with the Securities and Exchange Commission on August 15, 2025. Registration No. 333- United states SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Sensus Healthcare, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 27-1647271 (State of incorporation) (I.R.S. Employer Identification Number) 851 |
|
| August 15, 2025 |
EXHIBIT 107 Calculation of Filing Fee Table Form S-8 (Form Type) SENSUS HEALTHCARE, INC. |
|
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensus Healthcare, In |
|
| August 7, 2025 |
Sensus Healthcare Reports Second Quarter 2025 Financial Results Exhibit 99.1 Sensus Healthcare Reports Second Quarter 2025 Financial Results ● Shipped 19 SRT systems during the quarter, including four to China ● Revenues of $7.3 million ● FDA treatment volume increased 27% over the first quarter ● Exited the quarter with $22.2 million in cash and no debt ● Proposed Physician Fee Schedule expected to favorably impact adoption of SRT technology beginning in 2026 |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 SENSUS HEALTHCARE, INC. |
|
| June 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2025 SENSUS HEALTHCARE, INC. |
|
| May 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SENSUS HEALTHCARE, INC. |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensus Healthcare, I |
|
| May 15, 2025 |
Exhibit 99.1 Sensus Healthcare Reports First Quarter 2025 Financial Results 21 SRT systems shipped during the quarter; revenues of $8.3 million 65% increase in treatment volume from FDAs over preceding quarter Profitability forecast for the next three quarters and for the full year Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (May 15, 2025) – Sensus Healthcare, Inc. (Nas |
|
| May 15, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2025 SENSUS HEALTHCARE, INC. |
|
| April 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of |
|
| March 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensus Healthcare, Inc. ( |
|
| March 5, 2025 |
Sensus Healthcare, Inc. Insider Trading Policy Exhibit 19.1 Sensus Healthcare, Inc. Insider Trading Policy This Insider Trading Policy describes the standards of Sensus Healthcare, Inc. on trading in securities of the Company, and securities of certain other publicly traded companies while in possession of material, non-public information about the Company or such other companies. It also prohibits communicating any confidential information ab |
|
| February 11, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2025 SENSUS HEALTHCARE, INC. |
|
| February 11, 2025 |
Sensus Healthcare Buys Back Shares Exhibit 99.1 Sensus Healthcare Buys Back Shares BOCA RATON, Fla. (February 11, 2025) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces that the company has resumed purchasing shares of its common stock in open-market transa |
|
| February 5, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2025 SENSUS HEALTHCARE, INC. |
|
| February 5, 2025 |
Exhibit 99.1 Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results Shipped a record 39 SRT systems during the quarter; revenues of $13.1 million Achieved fifth consecutive quarter of profitability; diluted EPS of $0.09 Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (February 5, 2025) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company |
|
| November 18, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2024 SENSUS HEALTHCARE, INC. |
|
| November 18, 2024 |
SENSUS HEALTHCARE, INC. GAAP TO NON-GAAP RECONCILIATION Exhibit 99.1 This revised news release replaces the one issued on November 14, 2024, contains several non-financial changes throughout and removes the name of and references to a new customer, at the customer’s request. The agreement with the new customer remains in effect. Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter ● R |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensus Healthcar |
|
| November 14, 2024 |
Exhibit 99.1 Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter ● Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year ago ● Signed a Fair Deal Agreement with Platinum Dermatology, a leading dermatology netwo |
|
| November 14, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2024 SENSUS HEALTHCARE, INC. |
|
| November 14, 2024 |
Exhibit 10.2 AMENDMENT NO. 1 TO MASTER REVOLVING NOTE This Amendment No. 1 to Master Revolving Note (“Amendment”) is executed, delivered and made effective as of October 16, 2024 (“Amendment Effective Date”) by and between SENSUS HEALTHCARE, INC., a Delaware corporation (singularly and collectively, if more than one party, “Borrower”), and COMERICA BANK, a Texas banking association (“Bank”). (a) B |
|
| November 14, 2024 |
Exhibit 10.1 AMENDMENT NO. 1 TO CREDIT AGREEMENT This Amendment No. 1 to Credit Agreement (“Amendment”) dated October 16, 2024 (“Amendment Effective Date”) is made between SENSUS HEALTHCARE, INC., a Delaware corporation (singularly and collectively, if more than one party, “Borrower”), and COMERICA BANK, a Texas banking association (“Bank”). (a) Borrower and Bank entered into a Credit Agreement da |
|
| September 11, 2024 |
Exhibit 16.1 September 9, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Sensus Healthcare, Inc. under Item 4.01 of its Form 8-K dated September 5, 2024. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Sensus Healthcare, Inc. |
|
| September 11, 2024 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2024 SENSUS HEALTHCARE, INC. |
|
| August 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensus Healthcare, In |
|
| August 13, 2024 |
Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SENSUS HEALTHCARE, INC. Sensus Healthcare, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows: 1. The name of the Corporation is Sensus Healthcare, Inc. The Corporation’s original Certificate of Incorporation was filed with the Secretary of State of the |
|
| August 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 SENSUS HEALTHCARE, INC. |
|
| August 8, 2024 |
Exhibit 99.1 Sensus Healthcare Reports Second Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Second Quarter ● Revenues of $9.2 million compare with $4.5 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $2.1 million compares with negative $1.0 million a year ago ● “Fair Deal Agreement” recurring revenue program gaining momentum with 15 agreemen |
|
| June 5, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2024 SENSUS HEALTHCARE, INC. |
|
| May 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2024 SENSUS HEALTHCARE, INC. |
|
| May 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SENSUS HEALTHCARE, INC. |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensus Healthcare, I |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 SENSUS HEALTHCARE, INC. |
|
| May 9, 2024 |
Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold Exhibit 99.1 Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold · Revenues of $10.7 million, compared with $3.4 million in the prior-year quarter; Adjusted EBITDA (a non-GAAP measure) of $3.0 million, compared with negative $2.7 million in the prior-year quarter · Launched the “Fair Deal Agreement” recurring revenue program to provide an equipment |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of |
|
| April 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, For Use of |
|
| March 15, 2024 |
Sensus Healthcare, Inc. Clawback Policy Exhibit 97 Gunster Draft Sensus Healthcare, Inc. Clawback Policy Date of Last Approval: , 2023 Introduction The Board of Directors of the Company has adopted this Policy to provide for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under the federal securities laws. This Policy i |
|
| March 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensus Healthcare, Inc. ( |
|
| February 8, 2024 |
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results Exhibit 99.1 Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results ● Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditions ● Introduces recurring revenue model for the SRT-100 Vision™ (IG-SRT) to address dermatologist demand. Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. |
|
| February 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2024 SENSUS HEALTHCARE, INC. |
|
| February 6, 2024 |
SRTS / Sensus Healthcare, Inc. / Solot Edwin Lee Passive Investment SC 13G/A 1 formsc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 81728J109 (CUSIP Number) Edwin L. Solot, Jr. 10940 Wilshire Boulevard Suite 1600 PMG #874 Los Angeles, CA 90024 (310) 471-66 |
|
| February 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2024 SENSUS HEALTHCARE, INC. |
|
| January 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2024 SENSUS HEALTHCARE, INC. |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcar |
|
| November 9, 2023 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2023 SENSUS HEALTHCARE, INC. |
|
| November 9, 2023 |
Exhibit 99.1 Sensus Healthcare Reports Third Quarter 2023 Financial Results Revenues of $3.9 million reflect seasonality and macroeconomic conditions Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (November 9, 2023) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatm |
|
| September 14, 2023 |
Exhibit 10.1 CREDIT AGREEMENT This Agreement is entered into as of September 11, 2023, by and between Comerica Bank (“Bank”) and Sensus Healthcare, Inc., a Delaware corporation (singularly and collectively, if more than one party, “Borrower”). In consideration of all present and future loans and credit from time to time made available by Bank to or in favor of Borrower, and in consideration of all |
|
| September 14, 2023 |
BUNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2023 SENSUS HEALTHCARE, INC. |
|
| September 14, 2023 |
Exhibit 10.2 Master Revolving Note Daily Adjusting Term Secured Overnight Financing Rate (SOFR) Demand - Obligatory Advances (Business and Commercial Loans Only) AMOUNT $10,000,000.00 NOTE DATE September 11, 2023 MATURITY DATE ON DEMAND 1. Promise to Pay. ON DEMAND (or as otherwise provided in this Note), FOR VALUE RECEIVED, SENSUS HEALTHCARE, INC., a Delaware corporation (singularly and collectiv |
|
| September 14, 2023 |
Exhibit 10.3 SECURITY AGREEMENT As of September 11, 2023, for value received, the undersigned (“Pledgor” or “Borrower”) pledges, assigns and grants to Comerica Bank (“Bank”), a continuing security interest and lien (any pledge, assignment, security interest or other lien arising hereunder is sometimes referred to herein as a “security interest”) in the Collateral (as defined below) to secure payme |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 SENSUS HEALTHCARE, INC. |
|
| August 11, 2023 |
Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is made as of June 1, 2023, between Sensus Healthcare, Inc., a Delaware corporation (together with its subsidiaries, the “Company”) and Javier Rampolla (the “Executive”). WHEREAS, the Company desires to employ the Executive and the Executive desires to be employed by the Company, on the terms and conditions provided bel |
|
| August 11, 2023 |
As filed with the Securities and Exchange Commission on August 11, 2023. As filed with the Securities and Exchange Commission on August 11, 2023. Registration No. 333- United states SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Sensus Healthcare, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 27-1647271 (State of incorporation) (I.R.S. Employer Identification Number) 851 |
|
| August 11, 2023 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) SENSUS HEALTHCARE, INC. |
|
| August 11, 2023 |
Press Release, dated as of August 8, 2023. Exhibit 10.1 Sensus Healthcare Announces New $3 Million Share Repurchase Program BOCA RATON, Fla. (August 8, 2023) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its Board of Directors has authorized a new share repurcha |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Commission File Number: 001-37714 Sensus Healthcare, Inc |
|
| August 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2023 SENSUS HEALTHCARE, INC. |
|
| August 3, 2023 |
Sensus Healthcare Reports Second Quarter 2023 Financial Results Exhibit 99.1 Sensus Healthcare Reports Second Quarter 2023 Financial Results ● Revenues increased 33% and system shipments increased 30%, both compared with the first quarter of 2023 ● Achieved a milestone with the installation of 700 systems for a total of 708 ● Expects to ship at least 60 SRT units during 2023 and to return to profitability in the second half of the year Conference call begins a |
|
| June 6, 2023 |
Employment Agreement, dated as of June 1, 2023, by and between the Company and Javier Rampolla. Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is made as of June 1, 2023, between Sensus Healthcare, Inc., a Delaware corporation (together with its subsidiaries, the “Company”) and Javier Rampolla (the “Executive”). WHEREAS, the Company desires to employ the Executive and the Executive desires to be employed by the Company, on the terms and conditions provided bel |
|
| June 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2023 SENSUS HEALTHCARE, INC. |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcare, I |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2023 SENSUS HEALTHCARE, INC. |
|
| May 3, 2023 |
Exhibit 99.1 Sensus Healthcare Reports First Quarter 2023 Financial Results Lower demand for SRT systems reflects the impact of inflation on dermatologists’ cash flow from fewer elective aesthetic procedures and higher operating costs Sensus expects to ship more than 60 SRT units during 2023 and return to profitability in the second half of the year Conference call begins at 4:30 p.m. Eastern time |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of |
|
| April 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, For Use of |
|
| March 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensus Healthcare, Inc. ( |
|
| February 10, 2023 |
SRTS / Sensus Healthcare Inc / Solot Edwin Lee Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 81728J109 (CUSIP Number) Edwin L. Solot, Jr. 10940 Wilshire Boulevard Suite 1600 PMG #874 Los Angeles, CA 90024 (310) 471-6634 (Name, Address and Tele |
|
| February 9, 2023 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2023 SENSUS HEALTHCARE, INC. |
|
| February 9, 2023 |
Exhibit 99.1 Sensus Healthcare Fourth Quarter 2022 Financial Results Include Quarterly Revenues of $13.1 Million Full-year revenues increased 65% to $44.5 million Investments in technology and staff position Sensus for growth in 2023 and beyond Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (February 9, 2023) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device compa |
|
| January 9, 2023 |
EX-99.1 2 ea171415ex99-1sensus.htm PRESS RELEASE, DATED JANUARY 5, 2023. Exhibit 99.1 Sensus Healthcare Announces Preliminary Fourth Quarter 2022 Revenues Fourth quarter revenues to exceed $13 million; full year revenues to exceed $44 million, representing growth of 60% BOCA RATON, Fla, Jan. 05, 2023 (GLOBE NEWSWIRE) - Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing i |
|
| January 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2023 SENSUS HEALTHCARE, INC. |
|
| November 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcar |
|
| November 3, 2022 |
Exhibit 99.1 Sensus Healthcare Reports Third Quarter 2022 Financial Results Profitability continues with revenues up 64% to $9.0 million, diluted EPS of $0.11 compares with $0.01 a year ago Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (November 3, 2022) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, mini |
|
| November 3, 2022 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2022 SENSUS HEALTHCARE, INC. |
|
| August 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcare, In |
|
| August 4, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2022 SENSUS HEALTHCARE, INC. |
|
| August 4, 2022 |
Exhibit 99.1 Sensus Healthcare Second Quarter 2022 Financial Results Feature Revenue Growth of 124% Diluted EPS of $0.21 compares with $(0.02) for the year-ago quarter Affirms expectations for full-year profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (August 4, 2022) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effe |
|
| June 9, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2022 SENSUS HEALTHCARE, INC. |
|
| May 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcare, I |
|
| May 12, 2022 |
Exhibit 10.1 SEVENTH AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT This Seventh Amendment to Second Amended and Restated Loan and Security Agreement (this ?Amendment?) is entered into as of April 27, 2022, by and between Silicon Valley Bank (?Bank?) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (?Borrower?), whose address is 851 Broken So |
|
| May 5, 2022 |
Exhibit 99.1 Sensus Healthcare First Quarter 2022 Financial Results Feature Revenue Growth of 237% Diluted EPS from operations of $0.20 compare with $(0.07) in the year-ago quarter Affirms expectations for continued growth in the second quarter and full year profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (May 5, 2022) ? Sensus Healthcare, Inc. (Nasdaq: SRTS), |
|
| May 5, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2022 SENSUS HEALTHCARE, INC. |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of |
|
| March 25, 2022 |
Exhibit 2.3 EXECUTION DOCUMENT ASSET PURCHASE AGREEMENT Between SENSUS HEALTHCARE, INC. And EMPYREAN MEDICAL SYSTEMS, INC. dated as of February 25, 2022 TABLE OF CONTENTS Page ARTICLE I Purchase and Sale 1 Section 1.01 Purchase and Sale of Assets 1 Section 1.02 Assumption of Liabilities 1 Section 1.03 Purchase Price 1 Section 1.04 Allocation of Purchase Price 2 Section 1.05 Withholding Tax 2 ARTIC |
|
| March 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensus Healthcare, Inc. ( |
|
| March 9, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2022 SENSUS HEALTHCARE, INC. |
|
| March 9, 2022 |
Sensus Healthcare Announces Share Repurchase Program Exhibit 99.1 Sensus Healthcare Announces Share Repurchase Program BOCA RATON, Fla. (March 9, 2022) ? Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its Board of Directors has authorized a program to purchase up to $3,000,0 |
|
| March 3, 2022 |
Exhibit 2.1 EXECUTION DOCUMENT ASSET PURCHASE AGREEMENT Between SENSUS HEALTHCARE, INC. And EMPYREAN MEDICAL SYSTEMS, INC. dated as of February 25, 2022 TABLE OF CONTENTS Page ARTICLE I Purchase and Sale 1 Section 1.01 Purchase and Sale of Assets 1 Section 1.02 Assumption of Liabilities 1 Section 1.03 Purchase Price 1 Section 1.04 Allocation of Purchase Price 2 Section 1.05 Withholding Tax 2 ARTIC |
|
| March 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2022 SENSUS HEALTHCARE, INC. |
|
| February 10, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2022 SENSUS HEALTHCARE, INC. |
|
| February 10, 2022 |
Exhibit 99.1 Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter 4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively Affirms expectations for 1Q22 continued growth and full-year 2022 profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (February 10, 2022) ? Sensus Healthcare, Inc. (Nasdaq: SRTS), a medic |
|
| February 7, 2022 |
SRTS / Sensus Healthcare Inc / Solot Edwin Lee Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 81728J109 (CUSIP Number) Edwin L. Solot, Jr. 10940 Wilshire Boulevard Suite 1600 PMG #874 Los Angeles, CA 90024 (310) 471-6634 (Name, Address and Tele |
|
| January 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2022 SENSUS HEALTHCARE, INC. |
|
| January 5, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2022 SENSUS HEALTHCARE, INC. |
|
| January 5, 2022 |
Exhibit 99.1 Sensus Healthcare Expects Record 4Q 2021 Sales and Continued Growth in 1Q 2022; Profiles New Product at the 2022 Winter Clinical Dermatology Conference Expects profitability for the 2021 fourth quarter and full year Physician KOL presentation at the Winter Clinical to highlight the TransDermal Infusion System? BOCA RATON, Fla. (January 5, 2022) ? Sensus Healthcare, Inc. (Nasdaq: SRTS) |
|
| November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcar |
|
| November 4, 2021 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2021 SENSUS HEALTHCARE, INC. |
|
| November 4, 2021 |
Exhibit 99.1 Sensus Healthcare Reports Third Quarter 2021 Financial Results Achieves profitability on revenues of $5.5 million, up sharply from $1.6 million a year ago Affirms expectations for continued growth in 4Q and full-year profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (November 4, 2021) ? Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device compan |
|
| September 10, 2021 |
SRTS / Sensus Healthcare Inc / Solot Edwin Lee Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 81728J109 (CUSIP Number) Edwin L. Solot, Jr. 10940 Wilshire Boulevard Suite 1600 PMG #874 Los Angeles, CA 90024 (310) 471-6634 (Name, Address and Telepho |
|
| August 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcare, In |
|
| August 5, 2021 |
Exhibit 99.1 Sensus Healthcare Reports Second Quarter 2021 Financial Results Revenues of $5.4 million up 358% year-over-year, up 77% sequentially Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (August 5, 2021) ? Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments f |
|
| August 5, 2021 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2021 SENSUS HEALTHCARE, INC. |
|
| June 4, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2021 SENSUS HEALTHCARE, INC. |
|
| May 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcare, I |
|
| May 6, 2021 |
Exhibit 99.1 Sensus Healthcare Reports First Quarter 2021 Financial Results Revenues up 83% year-over-year Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (May 6, 2021) ? Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditi |
|
| May 6, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2021 SENSUS HEALTHCARE, INC. |
|
| April 30, 2021 |
DEF 14A 1 def14a0421sensushealthcare.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant S Filed by a Party other than the Registrant £ Check the appro |
|
| March 5, 2021 |
Exhibit 10.8 Manufacturing Agreement July 20, 2010 Operations Function Company Confidential ? 2010 ? All Rights Reserved Do Not Copy or Distribute Without a Written Permission from Sensus Healthcare, LLC. Company Confidential ? 2010 ? All Rights Reserved Page 1 of 17 CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMP |
|
| March 5, 2021 |
Exhibit 10.12 THIRD Amendment to SECOND AMENDED AND RESTATED Loan and security agreement This Third Amendment to Second Amended and Restated Loan and Security Agreement (this ?Amendment?) is entered into as of October 31, 2017, by and between Silicon Valley Bank (?Bank?) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (?Borrower?), whose address is 851 Broken Sou |
|
| March 5, 2021 |
Exhibit 10.16 FIFTH Amendment to SECOND AMENDED AND RESTATED Loan and security agreement This Fifth Amendment to Second Amended and Restated Loan and Security Agreement (this ?Amendment?) is entered into as of January 31, 2020, by and between Silicon Valley Bank (?Bank?) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (?Borrower?), whose address is 851 Broken Sou |
|
| March 5, 2021 |
Exhibit 10.11 SECOND Amendment to SECOND AMENDED AND RESTATED Loan and security agreement This Second Amendment to Second Amended and Restated Loan and Security Agreement (this ?Amendment?) is entered into as of September , 2017, by and between Silicon Valley Bank (?Bank?) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (?Borrower?), whose address is 851 Broken S |
|
| March 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensus Healthcare, Inc. ( |
|
| February 25, 2021 |
Exhibit 99.1 Sensus Healthcare Reports Fourth Quarter and Full Year 2020 Financial Results Achieves fourth quarter net income of $1.0 million on revenues of $5.1 million Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (February 25, 2021) ? Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and |
|
| February 25, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2021 SENSUS HEALTHCARE, INC. |
|
| November 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcar |
|
| November 5, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2020 SENSUS HEALTHCARE, INC. |
|
| November 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2020 SENSUS HEALTHCARE, INC. |
|
| November 5, 2020 |
Exhibit 99.1 Sensus Healthcare Reports Third Quarter 2020 Financial Results Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (November 5, 2020) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial r |
|
| October 2, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensu |
|
| August 10, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcare, In |
|
| August 6, 2020 |
Exhibit 99.1 Sensus Healthcare Reports Second Quarter 2020 Financial Results Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (August 6, 2020) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial re |
|
| August 6, 2020 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2020 SENSUS HEALTHCARE, INC. |
|
| August 4, 2020 |
Exhibit 99.1 Sensus Healthcare Acquires Two Mobile Aesthetic Laser Companies in Florida • Establishes new line of business, adds recurring revenue stream while more than doubling dermatology customer base across the state • Expected to add $1.0 million in revenues over the next 12 months and to be immediately accretive to earnings • Management from both companies to assume leadership roles at new |
|
| August 4, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2020 SENSUS HEALTHCARE, INC. |
|
| June 5, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2020 SENSUS HEALTHCARE, INC. |
|
| June 4, 2020 |
form25 |
|
| June 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2020 SENSUS HEALTHCARE, INC. |
|
| May 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SENSUS HEALTHCARE, INC. |
|
| May 11, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcare, I |
|
| May 11, 2020 |
EX-10.1 2 f10q0320ex10-1sensushealth.htm SIXTH AMENDMENT TO SECOND AMENDMENT AND RESTATED LOAN AND SECURITY AGREEMENT, DATED APRIL 13, 2020 Exhibit 10.1 SIXTH AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT This Sixth Amendment to Second Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of April 13, 2020, by and between Silicon Valley Bank |
|
| May 7, 2020 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2020 SENSUS HEALTHCARE, INC. |
|
| May 7, 2020 |
Exhibit 99.1 Sensus Healthcare Reports First Quarter 2020 Financial Results Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (May 7, 2020) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial result |
|
| May 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant S Filed by a Party other than the Registrant £ Check the appropriate box: £ Preliminary Proxy Statement £ Confid |
|
| April 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant S Filed by a Party other than the Registrant £ Check the appropriate box: £ Preliminary Proxy Statement £ Confidential, For Use of |
|
| March 6, 2020 |
EX-4.4 2 f10k2019ex4-4sensushealth.htm DESCRIPTION OF COMPANY'S COMMON STOCK Exhibit 4.4 SENSUS HEALTHCARE, INC. DESCRIPTION OF CAPITAL STOCK Our common stock is listed on the Nasdaq Capital Market under the symbol “SRTS.” All outstanding shares of common stock are validly issued, fully paid, and nonassessable. Common stock The following is a summary of the material provisions of our capital stock |
|
| March 6, 2020 |
SRTS / Sensus Healthcare, Inc. 10-K - Annual Report - ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensus Healthcare, Inc. ( |
|
| February 13, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2020 SENSUS HEALTHCARE, INC. |
|
| February 13, 2020 |
Exhibit 99.1 Sensus Healthcare Reports Fourth Quarter and Full Year 2019 Financial Results Fourth quarter net income up 10-fold to $1.0 million, diluted EPS of $0.06 Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (February 13, 2020) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost |
|
| January 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2020 SENSUS HEALTHCARE, INC. |
|
| November 8, 2019 |
EX-10.1 2 f10q0919ex10-1sensushealth.htm FOURTH AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT, DATED OCTOBER 31, 2019. Exhibit 10.1 FOURTH Amendment to SECOND AMENDED AND RESTATED Loan and security agreement This Fourth Amendment to Second Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of October 28, 2019, by and between Silicon Valley |
|
| November 8, 2019 |
SRTS / Sensus Healthcare, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcar |
|
| November 6, 2019 |
EX-99.1 2 f8k110719ex99-1sensushealth.htm PRESS RELEASE, DATED NOVEMBER 6, 2019 Exhibit 99.1 Sensus Healthcare Reports Third Quarter 2019 Financial Results Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (November 6, 2019) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective |
|
| November 6, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 f8k110719sensushealthcare.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2019 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State o |
|
| August 12, 2019 |
Exhibit 4.1 AMENDMENT NO. 1 TO WARRANT AGREEMENT THIS AMENDMENT NO. 1 TO WARRANT AGREEMENT (this “Amendment”) is hereby entered into between Sensus Healthcare, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company, as Warrant Agent (the “Warrant Agent”) as of June 4, 2019 (the “Effective Date”). WITNESSETH: WHEREA |
|
| August 12, 2019 |
SRTS / Sensus Healthcare, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcare, In |
|
| August 8, 2019 |
Sensus Healthcare Reports Second Quarter 2019 Financial Results EX-99.1 2 f8k080819ex99-1sensus.htm PRESS RELEASE, DATED AUGUST 8, 2019 Exhibit 99.1 AUGUST 5, 2019 Sensus Healthcare Reports Second Quarter 2019 Financial Results ● Resumes double-digit revenue growth, up 23% over the prior year quarter ● Affirms expectations for full-year double-digit revenue growth ● Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (August 8, 2019) – Sens |
|
| August 8, 2019 |
Results of Operations and Financial Condition, Financial Statements and Exhibits 8-K 1 f8k080819sensushealthcare.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2019 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State of |
|
| June 7, 2019 |
Submission of Matters to a Vote of Security Holders 8-K 1 f8k060719sensushealthcare.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2019 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State of In |
|
| June 4, 2019 |
The date of this Prospectus Supplement is June 4, 2019 Filed Pursuant to Rule 424(b)(3) Registration No. 333-209451 PROSPECTUS Supplement 2,000,000 Units Sensus Healthcare, Inc. This Prospectus Supplement (this “Supplement”) amends and supplements the information contained in our Prospectus dated June 2, 2016 (the “Prospectus”). The Prospectus forms a part of our Registration Statement on Form S-1, Registration No. 333-209451, which we filed with the |
|
| June 4, 2019 |
Exhibit 4.1 AMENDMENT NO. 1 TO WARRANT AGREEMENT THIS AMENDMENT NO. 1 TO WARRANT AGREEMENT (this “Amendment”) is hereby entered into between Sensus Healthcare, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company, as Warrant Agent (the “Warrant Agent”) as of June 4, 2019 (the “Effective Date”). WITNESSETH: WHEREA |
|
| June 4, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2019 SENSUS HEALTHCARE, INC. |
|
| May 31, 2019 |
SRTS / Sensus Healthcare, Inc. SD - - SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SENSUS HEALTHCARE, INC. |
|
| May 14, 2019 |
SRTS / Sensus Healthcare, Inc. 10-Q Quarterly Report 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcare, I |
|
| May 9, 2019 |
Sensus Healthcare Reports First Quarter 2019 Financial Results EX-99.1 2 s118120ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Sensus Healthcare Reports First Quarter 2019 Financial Results · Premier, Inc. adds SRT to its group purchasing contracts · Ships second Sculptura™ system to Rabin Medical Center in Israel · Reaffirms expectations for double-digit full-year revenue growth · Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (May 9, 2019) – |
|
| May 9, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 s1181208k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2019 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State of Incorporation) (Commission Fil |
|
| April 26, 2019 |
SRTS / Sensus Healthcare, Inc. DEF 14A DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of |
|
| March 15, 2019 |
SRTS / Sensus Healthcare, Inc. 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37714 Sensus Healthcare, Inc. ( |
|
| February 14, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2019 SENSUS HEALTHCARE, INC. |
|
| February 14, 2019 |
EX-99.1 2 s116067ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Sensus Healthcare Fourth Quarter Financial Results Feature Record Revenue and Continued Double-digit Growth Shipped 27 systems during the quarter including 15 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (February 14, 2019) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company spec |
|
| November 6, 2018 |
SRTS / Sensus Healthcare, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcar |
|
| November 1, 2018 |
Exhibit 99.1 Sensus Healthcare Third Quarter Financial Results Feature Revenue Growth of 32% Shipped 18 systems during the quarter including 15 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (November 1, 2018) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers an |
|
| November 1, 2018 |
Results of Operations and Financial Condition, Financial Statements and Exhibits 8-K 1 s1135608k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2018 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State of Incorporation) (Commissio |
|
| September 21, 2018 |
Sensus Healthcare, Inc. Announces Underwriters’ Exercise of Option Exhibit 99.1 Sensus Healthcare, Inc. Announces Underwriters’ Exercise of Option BOCA RATON, Fla., September 21, 2018 – Sensus Healthcare, Inc. [Nasdaq:SRTS] announced today that it has issued an additional 330,882 shares of its common stock pursuant to the exercise in full of the underwriters’ option received in connection with Sensus’ recently completed public offering of its common stock. After |
|
| September 21, 2018 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2018 SENSUS HEALTHCARE, INC. |
|
| September 17, 2018 |
EX-1.1 2 s112712ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 Execution Version 2,205,882 Shares SENSUS HEALTHCARE, INC. Common Stock ($0.01 Par Value) UNDERWRITING AGREEMENT September 13, 2018 B. Riley FBR, Inc. As Representative of the Several Underwriters B. Riley FBR, Inc. 299 Park Avenue, 7th Floor New York, New York 10171 Ladies and Gentlemen: Sensus Healthcare, Inc., a Delaware corporation (the “Compan |
|
| September 17, 2018 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 s1127128k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2018 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State of Incorporation) (Commiss |
|
| September 13, 2018 |
Filed Pursuant to Rule 424(b)(5) Registration Statement Number: 333-221371 PROSPECTUS SUPPLEMENT (to Prospectus Dated December 7, 2017) 2,205,882 Shares Common Stock We are offering shares of our common stock. |
|
| September 12, 2018 |
SUBJECT TO COMPLETION, DATED SEPTEMBER 12, 2018 Filed Pursuant to Rule 424(b)(2) Registration Numbers: 333-221371 The information in this preliminary prospectus supplement is not complete and may be changed. |
|
| August 14, 2018 |
SRTS / Sensus Healthcare, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcare, In |
|
| August 2, 2018 |
EX-99.1 2 s111752ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Sensus Healthcare Second Quarter Financial Results Feature Continued Strong Revenue Growth Ships 21 systems including 12 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (August 2, 2018) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of |
|
| August 2, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 s1117528k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2018 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State of Incorporation) (Commission |
|
| June 11, 2018 |
Submission of Matters to a Vote of Security Holders 8-K 1 s1107608k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2018 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State of Incorporation) (Commission Fi |
|
| May 31, 2018 |
SRTS / Sensus Healthcare, Inc. SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SENSUS HEALTHCARE, INC. |
|
| May 8, 2018 |
EX-10.1 2 s110006ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is made as of April 1, 2018, between Sensus Healthcare, Inc., a Delaware corporation (together with its subsidiaries, the “Company”) and Michael J. Sardano (the “Executive”). WHEREAS, the Company desires to employ the Executive and the Executive desires to be employed by the Comp |
|
| May 8, 2018 |
SRTS / Sensus Healthcare, Inc. 10-Q (Quarterly Report) 10-Q 1 s11000610q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001 |
|
| May 3, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 s1099128k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2018 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State of Incorporation) (Commission Fil |
|
| May 3, 2018 |
EX-99.1 2 s109912ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Sensus Healthcare Reports First Quarter Financial Results Featuring 37% Revenue Growth Ships 21 systems with SRT-100 Vision™ systems sales continuing to rise Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (May 3, 2018) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive tr |
|
| April 26, 2018 |
SRTS / Sensus Healthcare, Inc. DEFA14A DEFA14A 1 s109784defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy |
|
| April 26, 2018 |
SRTS / Sensus Healthcare, Inc. DEF 14A DEF 14A 1 s109787def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy |
|
| February 15, 2018 |
SRTS / Sensus Healthcare, Inc. 10-K (Annual Report) 10-K 1 s10903810k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-3771 |
|
| February 14, 2018 |
SRTS / Sensus Healthcare, Inc. / Cohen Stephen Brad - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2 Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $.01 Par Value Per Share (Title of Class of Securities) 81728H103 (CUSIP Number) December 31, 2017 (Date of |
|
| February 14, 2018 |
SRTS / Sensus Healthcare, Inc. / Golin Richard - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2 Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $.01 Par Value Per Share (Title of Class of Securities) 81728H103 (CUSIP Number) December 31, 2017 (Date of |
|
| February 14, 2018 |
SRTS / Sensus Healthcare, Inc. / Fishman Kalman - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2 Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $.01 Par Value Per Share (Title of Class of Securities) 81728H103 (CUSIP Number) December 31, 2017 (Date of |
|
| February 14, 2018 |
SRTS / Sensus Healthcare, Inc. / Sardano Joseph C - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2 Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $.01 Par Value Per Share (Title of Class of Securities) 81728H103 (CUSIP Number) December 31, 2017 (Date of |
|
| February 1, 2018 |
Exhibit 99.1 Sensus Healthcare Reports Record Revenue for 2017 Fourth Quarter and Full Year Ninth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (February 1, 2018) ? Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and ke |
|
| February 1, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2018 SENSUS HEALTHCARE, INC. |
|
| December 5, 2017 |
SRTS / Sensus Healthcare, Inc. ESP CORRESP 1 filename1.htm SENSUS HEALTHCARE, INC 851 Broken Sound Parkway Boca Raton, FL 33487 December 5, 2017 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Caleb French Re: Sensus Healthcare, Inc. — Request for Acceleration Registration Statement on Form S-3 File No. 333-221371 Dear Mr. French: Pursuant to Rul |
|
| November 6, 2017 |
Exhibit 10.2 RESTRICTED STOCK AWARD AGREEMENT This Restricted Stock Award Agreement (this ?Agreement?) sets forth the terms of a Restricted Stock Award granted on (?Effective Date?) by Sensus Healthcare, Inc., a Delaware corporation (?Sensus?) to (?Grantee?). Capitalized terms used but not defined in this Agreement have the meanings ascribed to them in the Plan (as defined below). RECITALS A. The |
|
| November 6, 2017 |
SRTS / Sensus Healthcare, Inc. S-8 As filed with the Securities and Exchange Commission on November 6, 2017. Registration No. 333- United states SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Sensus Healthcare, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 27-1647271 (State of incorporation) (I.R.S. Employer Identification Number) 851 |
|
| November 6, 2017 |
Exhibit 10.2 RESTRICTED STOCK AWARD AGREEMENT This Restricted Stock Award Agreement (this ?Agreement?) sets forth the terms of a Restricted Stock Award granted on (?Effective Date?) by Sensus Healthcare, Inc., a Delaware corporation (?Sensus?) to (?Grantee?). Capitalized terms used but not defined in this Agreement have the meanings ascribed to them in the Plan (as defined below). RECITALS A. The |
|
| November 6, 2017 |
EXHIBIT 4.2 SENSUS HEALTHCARE, INC. INDENTURE Dated as of , , as Trustee Table of Contents Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1 Definitions 1 Section 1.2 Other Definitions 4 Section 1.3 Incorporation by Reference of Trust Indenture Act 4 Section 1.4 Rules of Construction 4 ARTICLE II THE SECURITIES 5 Section 2.1 Issuable in Series 5 Section 2.2 Establishment of T |
|
| November 6, 2017 |
EXHIBIT 4.2 SENSUS HEALTHCARE, INC. INDENTURE Dated as of , , as Trustee Table of Contents Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1 Definitions 1 Section 1.2 Other Definitions 4 Section 1.3 Incorporation by Reference of Trust Indenture Act 4 Section 1.4 Rules of Construction 4 ARTICLE II THE SECURITIES 5 Section 2.1 Issuable in Series 5 Section 2.2 Establishment of T |
|
| November 6, 2017 |
SRTS / Sensus Healthcare, Inc. S-3 As filed with the Securities and Exchange Commission on November 6, 2017 Registration No. |
|
| November 6, 2017 |
EX-10.2 3 s107962ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 THIRD Amendment to SECOND AMENDED AND RESTATED Loan and security agreement This Third Amendment to Second Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of October 31, 2017, by and between Silicon Valley Bank (“Bank”) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (“Bor |
|
| November 6, 2017 |
EX-10.2 3 s107962ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 THIRD Amendment to SECOND AMENDED AND RESTATED Loan and security agreement This Third Amendment to Second Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of October 31, 2017, by and between Silicon Valley Bank (“Bank”) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (“Bor |
|
| November 6, 2017 |
Exhibit 10.1 SECOND Amendment to SECOND AMENDED AND RESTATED Loan and security agreement This Second Amendment to Second Amended and Restated Loan and Security Agreement (this ?Amendment?) is entered into as of September , 2017, by and between Silicon Valley Bank (?Bank?) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (?Borrower?), whose address is 851 Broken So |
|
| November 6, 2017 |
Exhibit 10.1 SECOND Amendment to SECOND AMENDED AND RESTATED Loan and security agreement This Second Amendment to Second Amended and Restated Loan and Security Agreement (this ?Amendment?) is entered into as of September , 2017, by and between Silicon Valley Bank (?Bank?) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (?Borrower?), whose address is 851 Broken So |
|
| November 6, 2017 |
EX-10.2 3 s107962ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 THIRD Amendment to SECOND AMENDED AND RESTATED Loan and security agreement This Third Amendment to Second Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of October 31, 2017, by and between Silicon Valley Bank (“Bank”) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (“Bor |
|
| November 6, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcar |
|
| November 6, 2017 |
EX-10.2 3 s107962ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 THIRD Amendment to SECOND AMENDED AND RESTATED Loan and security agreement This Third Amendment to Second Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of October 31, 2017, by and between Silicon Valley Bank (“Bank”) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (“Bor |
|
| November 6, 2017 |
SRTS / Sensus Healthcare, Inc. ESP SENSUS HEALTHCARE, INC. 851 Broken Sound Parkway, NW #215 Boca Raton, FL 33487 November 6, 2017 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-4561 Re: Sensus Healthcare, Inc. Registration Statement on Form S-3 Filed November 6, 2017 File No. 333- Dear Sir or Madam: Sensus Healthcare, Inc., a Delaware corporation (the “Co |
|
| November 2, 2017 |
Exhibit 99.1 Sensus Healthcare Reports Third Quarter Financial Results Featuring Revenue up 44% Marks eighth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (November 2, 2017) ? Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin can |
|
| November 2, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 s1079638k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2017 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State of Incorporation) (Commissio |
|
| August 28, 2017 |
SRTS / Sensus Healthcare, Inc. / Cohen Stephen Brad - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2 Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $.01 Par Value Per Share (Title of Class of Securities) 81728H103 (CUSIP Number) December 31, 2016 (Date of |
|
| August 28, 2017 |
SRTS / Sensus Healthcare, Inc. / Fishman Kalman - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2 Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $.01 Par Value Per Share (Title of Class of Securities) 81728H103 (CUSIP Number) December 31, 2016 (Date of |
|
| August 28, 2017 |
SRTS / Sensus Healthcare, Inc. / Golin Richard - SC 13G Passive Investment SC 13G 1 s107358sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2 Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $.01 Par Value Per Share (Title of Class of Securities) 81728H103 (CUSIP Nu |
|
| August 28, 2017 |
SRTS / Sensus Healthcare, Inc. / Sardano Joseph C - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2 Sensus Healthcare, Inc. (Name of Issuer) Common Stock, $.01 Par Value Per Share (Title of Class of Securities) 81728H103 (CUSIP Number) December 31, 2016 (Date of |
|
| August 4, 2017 |
Exhibit 10.1 DEFAULT WAIVER AND First AMENDMENT TO Second Amended and Restated LOAN AND SECURITY AGREEMENT This Default Waiver and First Amendment to Second Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of June 27, 2017, by and between Silicon Valley Bank (“Bank”) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (“Borrower” |
|
| August 4, 2017 |
10-Q 1 s10700710q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001- |
|
| August 4, 2017 |
Exhibit 10.1 DEFAULT WAIVER AND First AMENDMENT TO Second Amended and Restated LOAN AND SECURITY AGREEMENT This Default Waiver and First Amendment to Second Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of June 27, 2017, by and between Silicon Valley Bank (“Bank”) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (“Borrower” |
|
| August 4, 2017 |
Exhibit 10.1 DEFAULT WAIVER AND First AMENDMENT TO Second Amended and Restated LOAN AND SECURITY AGREEMENT This Default Waiver and First Amendment to Second Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of June 27, 2017, by and between Silicon Valley Bank (“Bank”) and Sensus Healthcare, Inc. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (“Borrower” |
|
| August 3, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 s1070098k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2017 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State of Incorporation) (Commission |
|
| August 3, 2017 |
Exhibit 99.1 Sensus Healthcare Reports Record Second Quarter Financial Results Revenue growth of 39% marks seventh consecutive quarter of double-digit year-over-year gains Conference call begins at 4:30 Eastern time today BOCA RATON, Fla. (August 3, 2017) ? Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and k |
|
| June 9, 2017 |
Exhibit 10.1 SENSUS HEALTHCARE, INC. 2017 INCENTIVE PLAN ARTICLE 1 GENERAL PROVISIONS 1.1 Purpose. The 2017 Incentive Plan (the ?Plan?) of Sensus Healthcare, Inc. (the ?Company?) is adopted for the following purposes: (1) to closely associate the interests of certain Key Persons (as hereinafter defined) with the interests of the Company?s stockholders; (2) to encourage the Key Persons to focus on |
|
| June 9, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2017 SENSUS HEALTHCARE, INC. |
|
| June 9, 2017 |
Exhibit 10.1 SENSUS HEALTHCARE, INC. 2017 INCENTIVE PLAN ARTICLE 1 GENERAL PROVISIONS 1.1 Purpose. The 2017 Incentive Plan (the ?Plan?) of Sensus Healthcare, Inc. (the ?Company?) is adopted for the following purposes: (1) to closely associate the interests of certain Key Persons (as hereinafter defined) with the interests of the Company?s stockholders; (2) to encourage the Key Persons to focus on |
|
| May 9, 2017 |
Sensus Healthcare QUARTERLY REPORT (Quarterly Report) 10-Q 1 s10605010q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File |
|
| May 4, 2017 |
Exhibit 99.1 Sensus Healthcare First Quarter Financial Results Feature Revenues up 43% Sixth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 Eastern time today BOCA RATON, Fla. (May 4, 2017) ? Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with supe |
|
| May 4, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 s1060518k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2017 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State of Incorporation) (Commission Fil |
|
| April 21, 2017 |
DEFA14A 1 s105928defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy |
|
| April 21, 2017 |
DEF 14A 1 s105929def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy |
|
| April 21, 2017 |
DEFA14A 1 s105927defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy |
|
| April 12, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2017 SENSUS HEALTHCARE, INC. |
|
| March 24, 2017 |
8-K 1 s1056628k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2017 SENSUS HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-37714 27-1647271 (State of Incorporation) (Commis |
|
| March 10, 2017 |
Exhibit 10.15 November 16, 2016 Arthur Levine Sensus Healthcare, Inc. Chief Financial Officer 851 Broken Sound Parkway NW Suite 215 Boca Raton, FL 33487 Dear Arthur, This letter is in reference to our letter agreement with you, dated July 30, 2015 (the ?Original Letter?). In the Original Letter, each of Joseph C. Sardano, Stephen Cohen, Richard Golin, Kalman Fishman, and Stephen Arnold individuall |
|
| March 10, 2017 |
Sensus Healthcare 10-K (Annual Report) 10-K 1 s10550810k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-3771 |
|
| March 10, 2017 |
EX-21.1 3 s105508ex21-1.htm EXHIBIT 21-1 Exhibit 21.1 Subsidiaries None. |
|
| March 10, 2017 |
EX-21.1 3 s105508ex21-1.htm EXHIBIT 21-1 Exhibit 21.1 Subsidiaries None. |
|
| February 2, 2017 |
Sensus Healthcare Reports Fourth Quarter and Full Year 2016 Results Exhibit 99.1 Sensus Healthcare Reports Fourth Quarter and Full Year 2016 Results - Record Quarterly Revenues of $4.9 million in Fourth Quarter - Full Year 2016 revenues increased 44% year-over-year to $14.8 million - Worldwide installed base increased to 271 units BOCA RATON, Fla., Feb. 2, 2017 /PRNewswire/ ? Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the trea |
|
| February 2, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2017 SENSUS HEALTHCARE, INC. |
|
| January 25, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 20, 2017 SENSUS HEALTHCARE, INC. |
|
| November 21, 2016 |
EX-99.25 2 srtsu-form25.txt srtsu-form25 |
|
| November 7, 2016 |
EX-10.2 3 s104455ex10-2.htm EXHIBIT 10-2 Exhibit 10.2 COMMERCIAL LEASE THIS LEASE (“Lease”) dated 7 day of July, 2016, is made by and between BREF 851 LLC (the “Landlord”), and Sensus Healthcare. Inc. .(“Tenant”). WITNESSETH: Landlord hereby leases to Tenant and Tenant hereby leases from Landlord, the Premises described below for the term and subject to the terms, covenants and conditions hereinaf |
|
| November 7, 2016 |
EX-10.1 2 s104455ex10-1.htm EXHIBIT 10-1 Exhibit 10.1 SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of September 21, 2016 (the “Effective Date”) between SILICON VALLEY BANK, a California corporation (“Bank”), and SENSUS HEALTHCARE, INC. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (“Borrowe |
|
| November 7, 2016 |
Sensus Healthcare 10-Q (Quarterly Report) 10-Q 1 s10445510q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: |
|
| November 7, 2016 |
EX-10.1 2 s104455ex10-1.htm EXHIBIT 10-1 Exhibit 10.1 SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of September 21, 2016 (the “Effective Date”) between SILICON VALLEY BANK, a California corporation (“Bank”), and SENSUS HEALTHCARE, INC. (f/k/a Sensus Healthcare, LLC), a Delaware corporation (“Borrowe |
|
| November 4, 2016 |
Sensus Healthcare Reports Third Quarter 2016 Results EX-99.1 2 s104552ex99-1.htm EXHIBIT 99-1 Exhibit 99.1 Sensus Healthcare Reports Third Quarter 2016 Results - Q3 revenues increased 58% year-over-year to $3.33 million - Worldwide installed base increased to 256 units BOCA RATON, Fla., Nov. 3, 2016 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other ski |
|
| November 4, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2016 SENSUS HEALTHCARE, INC. |
|
| August 15, 2016 |
Exhibit 4.2 AMENDMENT NO. 3 TO WARRANT THIS AMENDMENT NO. 3 TO WARRANT (this “Amendment”) is hereby entered into between Sensus Healthcare, Inc., a Delaware corporation (the “Company”), and the undersigned warrant holder (“Holder”) as of May 27, 2016 (the “Effective Date”). WITNESSETH: WHEREAS, the Company previously issued a warrant, dated as of March 31, 2011 (the “Warrant”), to acquire equity i |
|
| August 15, 2016 |
Exhibit 4.2 AMENDMENT NO. 3 TO WARRANT THIS AMENDMENT NO. 3 TO WARRANT (this “Amendment”) is hereby entered into between Sensus Healthcare, Inc., a Delaware corporation (the “Company”), and the undersigned warrant holder (“Holder”) as of May 27, 2016 (the “Effective Date”). WITNESSETH: WHEREAS, the Company previously issued a warrant, dated as of March 31, 2011 (the “Warrant”), to acquire equity i |
|
| August 15, 2016 |
SRTS / Sensus Healthcare, Inc. 10-Q - Quarterly Report - FORM 10-Q 10-Q 1 v44619010q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: |
|
| August 15, 2016 |
Exhibit 4.2 AMENDMENT NO. 3 TO WARRANT THIS AMENDMENT NO. 3 TO WARRANT (this “Amendment”) is hereby entered into between Sensus Healthcare, Inc., a Delaware corporation (the “Company”), and the undersigned warrant holder (“Holder”) as of May 27, 2016 (the “Effective Date”). WITNESSETH: WHEREAS, the Company previously issued a warrant, dated as of March 31, 2011 (the “Warrant”), to acquire equity i |
|
| August 15, 2016 |
Exhibit 4.2 AMENDMENT NO. 3 TO WARRANT THIS AMENDMENT NO. 3 TO WARRANT (this “Amendment”) is hereby entered into between Sensus Healthcare, Inc., a Delaware corporation (the “Company”), and the undersigned warrant holder (“Holder”) as of May 27, 2016 (the “Effective Date”). WITNESSETH: WHEREAS, the Company previously issued a warrant, dated as of March 31, 2011 (the “Warrant”), to acquire equity i |
|
| August 4, 2016 |
EX-99.1 2 v446125ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 SENSUS HEALTHCARE REPORTS SECOND QUARTER 2016 RESULTS - Q2 revenues increased 49% year-over-year to $3.6 million - Worldwide installed base increased to 247 units -Successfully completed IPO on June 2nd; cash of $15.8 million, with no debt, at June 30, 2016 BOCA RATON, Fla. – August 4, 2016 – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical de |
|
| August 4, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2016 SENSUS HEALTHCARE, INC. |
|
| August 3, 2016 |
SRTS / Sensus Healthcare, Inc. / RTW INVESTMENTS, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Sensus Healthcare, Inc. |
|
| August 3, 2016 |
Joint Filing Statement Pursuant to Rule 13d-1(k)(1) Exhibit 1 Joint Filing Statement Pursuant to Rule 13d-1(k)(1) The undersigned hereby consent and agree to the joint filing of Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Units of Sensus Healthcare, Inc. |
|
| August 3, 2016 |
Joint Filing Statement Pursuant to Rule 13d-1(k)(1) Exhibit 1 Joint Filing Statement Pursuant to Rule 13d-1(k)(1) The undersigned hereby consent and agree to the joint filing of Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Units of Sensus Healthcare, Inc. |
